Vivo Bio Tech Allots Equity Shares on Warrant Conversion

MT Newswires Live
2025/03/04

Vivo Bio Tech (BOM:532660) allotted 740,000 equity shares at 45 Indian rupees each upon conversion of warrants issued on a preferential basis, according to an Indian bourse filing on Monday.

The company received around 25 million rupees in application money, the filing said.

Following the allotment, the company's issued and subscribed share capital increased to 168.7 million rupees, comprising 16.9 million equity shares of 10 rupees each.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10